Opentrons will use this fundraising round to further invest in its automated lab platform globally. Other investors in Opentrons include Sands Capital, Lerer Hippeau Ventures, SOSV, and Y Combinator.

Opentrons develops the integrated lab platform that serves life science and healthcare customers via the Opentrons Robotics, Pandemic Response Lab, and Neochromosome subsidiaries. Opentrons Robotics is a business unit of Opentrons Labworks Inc and is the industry leader in flexible, user-friendly lab automation. Opentrons Robotics flagship product, the OT-2, can be found in thousands of labs in more than 40 countries